Research review
Does magnesium glycinate help with asthma?
Oral magnesium trials for asthma are small and mixed, and the largest found no benefit at all. Magnesium used in hospitals for severe attacks is a different drug given a different way, and no trial has tested magnesium glycinate specifically.
The evidence doesn't support magnesium glycinate, or any oral magnesium supplement, as a treatment for asthma. The largest and most rigorous trial found no benefit on any measure of asthma control; two much smaller trials reported some lung-function and symptom improvements, but neither used magnesium glycinate specifically, and none of them replace an inhaler or a controller medication.
What the evidence doesn't support
It doesn't support oral magnesium, in any form, as a treatment for asthma, and it doesn't support magnesium glycinate specifically — no trial has tested that compound on an asthma outcome. It also doesn't support treating a daily oral supplement the way an emergency room treats a severe attack: intravenous and nebulized magnesium are different drugs, given at different doses, for a different clinical situation, under medical supervision, and none of that evidence transfers to a capsule taken at home.
What the trials found
The largest trial randomized 300 adults aged 18–60 with physician-diagnosed, inhaled-corticosteroid-controlled asthma to 450 mg/day of magnesium chelate, 1 g/day of vitamin C, or placebo for 16 weeks (Fogarty et al. 2003, Nottingham, UK, Clinical & Experimental Allergy). It found no benefit from either supplement on any outcome measure — lung function, airway responsiveness to methacholine, peak flow, symptom scores or bronchodilator use — in either the full analysis or the group that completed the study.
A smaller trial randomized 55 adults aged 21–55 with mild-to-moderate asthma to 340 mg/day of oral magnesium or placebo for 6.5 months (Kazaks et al. 2010, Journal of Asthma). Within the magnesium group, the dose of inhaled methacholine needed to trigger a 20% drop in lung function rose significantly, peak flow improved 5.8% of predicted (p=0.03), and both a quality-of-life questionnaire and a symptom-control questionnaire improved — but none of the blood, urine or tissue measures of magnesium status changed despite those reported improvements, a discrepancy the authors couldn't explain.
A third trial gave 300 mg/day of oral magnesium or placebo to 37 children and adolescents aged 7–19 with moderate persistent asthma, alongside their regular inhaled fluticasone, for 2 months (Gontijo-Amaral et al. 2007, European Journal of Clinical Nutrition). Airway reactivity to methacholine improved only in the magnesium group, allergen-induced skin responses decreased, and the magnesium group had fewer exacerbations and used less rescue inhaler — though measured lung function (FEV1, FVC) didn't differ between groups. It's a small trial in children already on prescribed asthma medication, not a basis for picking a dose for a child; that call belongs to a pediatrician, not a supplement label.
A 2007 review in Current Opinion in Allergy and Clinical Immunology summarized where the evidence for magnesium and asthma actually stood: meta-analyses had confirmed that intravenous and nebulized magnesium, given in a hospital alongside a bronchodilator, helped in severe acute asthma attacks, while long-term oral magnesium supplementation did not improve control in adult asthma (Beasley & Aldington 2007). Those are two different clinical situations, two different drugs and doses, and the hospital evidence says nothing about a daily oral capsule.
The trials above were run because observational studies had linked lower dietary magnesium intake to more asthma symptoms (Fogarty et al. 2003). A correlation between intake and symptoms in population data isn't the same as evidence that supplementing changes the outcome — the randomized trials that tested that directly were mostly null or mixed.
| Trial | Population | Dose & duration | Result |
|---|---|---|---|
| Fogarty 2003 | 300 adults, ICS-controlled asthma | 450 mg/day, 16 weeks | No benefit on any measure |
| Kazaks 2010 | 55 adults, mild-moderate asthma | 340 mg/day, 6.5 months | Within-group improvement in airway reactivity, peak flow, symptom scores |
| Gontijo-Amaral 2007 | 37 children/adolescents, moderate persistent asthma | 300 mg/day, 2 months | Improved bronchial reactivity, fewer exacerbations; lung function unchanged |
Questions people ask
Does magnesium glycinate help with asthma symptoms?
Not reliably. The largest trial found no effect on any measure of asthma control; two much smaller trials found improvements on some lung-function and symptom measures but not others, and neither used magnesium glycinate. Nobody has run a trial that isolates magnesium glycinate specifically for asthma.
Is IV magnesium the same as taking a magnesium supplement?
No. Intravenous and nebulized magnesium are given as medications, at hospital doses, for a severe attack in progress, under medical supervision — a different form, route, dose and clinical situation than a daily oral capsule. The trials on oral, at-home magnesium supplementation for long-term asthma control found no consistent benefit.
Does low magnesium cause asthma?
The trials above were run because observational studies had linked lower dietary magnesium intake to more asthma symptoms. A correlation between intake and symptoms in population data isn't the same as evidence that supplementing changes the outcome.
Can I take magnesium glycinate alongside asthma medication?
None of the trials above reported an interaction between magnesium and asthma medication, but asthma medication is prescribed and monitored by a doctor, and any supplement added alongside it is worth mentioning at your next visit or pharmacy consult.
When to talk to a doctor
Asthma is a diagnosed lung condition managed with prescription medication — controllers, inhalers, and in a severe attack, sometimes IV magnesium in an emergency room. Magnesium glycinate is not a treatment for asthma, and nothing in the trials above supports using a supplement in place of prescribed medication or as a way to reduce it. Worsening symptoms, more frequent rescue-inhaler use, or an asthma action plan that isn't holding are reasons to talk to a doctor, not to change a supplement.
Related reading: who shouldn't take magnesium glycinate, magnesium glycinate interactions, and magnesium glycinate side effects.
Sources
- Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial The largest randomized trial of oral magnesium for asthma (300 adults, 450 mg/day for 16 weeks) found no benefit on any measure of asthma control.
- Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial A small trial found within-group improvements in airway responsiveness, peak flow and symptom/quality-of-life questionnaires after 6.5 months of 340 mg/day oral magnesium, but no corresponding change in magnesium status markers.
- Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial In a small trial in children and adolescents already on inhaled asthma medication, 300 mg/day oral magnesium for 2 months improved bronchial reactivity and reduced exacerbations and rescue-inhaler use versus placebo, though measured lung function was unchanged in both groups.
- Magnesium in the treatment of asthma A 2007 review found that intravenous and nebulized magnesium (given in hospitals for severe acute asthma attacks) are supported by meta-analyses, while long-term oral magnesium supplementation does not improve asthma control in adults — two different questions with two different answers.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.